Search

Your search keyword '"Antimetabolites pharmacology"' showing total 14 results

Search Constraints

Start Over You searched for: Descriptor "Antimetabolites pharmacology" Remove constraint Descriptor: "Antimetabolites pharmacology" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
14 results on '"Antimetabolites pharmacology"'

Search Results

1. VEGF-C and 5-Fluorouracil Improve Bleb Survival in a Rabbit Glaucoma Surgery Trabeculectomy Model.

2. Development of Novel Class of Phenylpyrazolo[3,4- d ]pyrimidine-Based Analogs with Potent Anticancer Activity and Multitarget Enzyme Inhibition Supported by Docking Studies.

3. Nucleoside-based anticancer drugs: Mechanism of action and drug resistance.

4. An Organofluorine Isoselenocyanate Analogue of Sulforaphane Affects Antimetabolite 5-Fluorouracil's Anticancer Activity: A Perspective for New Combinatory Therapy in Triple-Negative Breast Cancer.

5. Methotrexate treatment suppresses osteoblastic differentiation by inducing Notch2 signaling and blockade of Notch2 rescues osteogenesis by preserving Wnt/β-catenin signaling.

6. Subconjunctival Lymphatics Respond to VEGFC and Anti-Metabolites in Rabbit and Mouse Eyes.

7. Steroidal Antimetabolites Protect Mice against Trypanosoma brucei .

8. Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target.

9. Antimetabolite Drugs Exhibit Distinctive Immunomodulatory Mechanisms and Effects on the Intestinal Microbiota in Experimental Autoimmune Uveitis.

10. Enhancing the Antiviral Potency of Nucleobases for Potential Broad-Spectrum Antiviral Therapies.

11. Metabolic regulation of RA macrophages is distinct from RA fibroblasts and blockade of glycolysis alleviates inflammatory phenotype in both cell types.

12. Hexokinases II-mediated glycolysis governs susceptibility to crizotinib in ALK-positive non-small cell lung cancer.

13. Phase II study of azacitidine with pembrolizumab in patients with intermediate-1 or higher-risk myelodysplastic syndrome.

14. Metabolic preconditioning in CD4+ T cells restores inducible immune tolerance in lupus-prone mice.

Catalog

Books, media, physical & digital resources